Autolus Therapeutics (AUTL) Net Cash Flow (2017 - 2025)
Autolus Therapeutics' (AUTL) quarterly Net Cash Flow came in at $17.4 million in Q4 2025, up 104.45% YoY from $8.5 million in Q4 2024, and up 151.05% on a QoQ basis from -$34.1 million in Q3 2025.
Autolus Therapeutics (AUTL) Net Cash Flow (2017 - 2025) Analysis & Trends
Autolus Therapeutics (AUTL) has 9 years of Net Cash Flow data on file, last reported at $17.4 million in Q4 2025.
- Quarterly Net Cash Flow rose 104.45% year-over-year to $17.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$129.4 million (down 1048.72% YoY) and the FY2025 annual result came in at -$129.4 million, down 1048.72% from the prior year.
- Net Cash Flow advanced to $17.4 million in Q4 2025, from -$34.1 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $520.4 million in Q1 2024 to a low of -$391.5 million in Q4 2024.
- A 5-year average of -$2.0 million and a median of -$35.0 million in 2022 frame the typical range for Net Cash Flow.
- The widest YoY moves for Net Cash Flow: up 1213.57% in 2024, down 1389.39% in 2024.
- Tracing AUTL's Net Cash Flow over 5 years: stood at $136.7 million in 2021, then soared by 52.42% to $208.3 million in 2022, then slumped by 112.62% to -$26.3 million in 2023, then slumped by 1389.39% to -$391.5 million in 2024, then jumped by 104.45% to $17.4 million in 2025.
- The last three Net Cash Flow figures came in at $17.4 million (Q4 2025), -$34.1 million (Q3 2025), and $22.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17.42 Mn |
| Dec 31, 2025 | 17.42 Mn |
| Sep 30, 2025 | -34.13 Mn |
| Sep 30, 2025 | -34.13 Mn |
| Jun 30, 2025 | 22.37 Mn |
| Jun 30, 2025 | 22.37 Mn |
| Mar 31, 2025 | -135.11 Mn |
| Mar 31, 2025 | -135.11 Mn |
| Dec 31, 2024 | -391.52 Mn |
| Dec 31, 2024 | -391.52 Mn |
| Sep 30, 2024 | -86.14 Mn |
| Sep 30, 2024 | -86.14 Mn |
| Jun 30, 2024 | -54.00 Mn |
| Jun 30, 2024 | -54.00 Mn |
| Mar 31, 2024 | 520.39 Mn |
| Mar 31, 2024 | 520.39 Mn |
| Dec 31, 2023 | -26.29 Mn |
| Dec 31, 2023 | -26.29 Mn |
| Sep 30, 2023 | -41.68 Mn |
| Sep 30, 2023 | -41.68 Mn |